Introductory lecture

08:30-09:00 Radiation therapy – a two edge sword, Iuliana Toma-Dasu

Session 1 – Epidemiological evidence for radiotherapy induced secondary cancer

Chairperson: tbd

09:00-09:40 Radiation epidemiology for cancer radiotherapy in the US, Lindsay Morton

09:40-10:20 Radiation epidemiology for cancer radiotherapy in Europe, Florent de Vathaire

Coffee break

10:40-11:20 Statistical methods in radiation epidemiology, Michael Hauptmann

11:20-12:00 The childhood cancer survivor study, Leslie L. Robison

 Lunch break

Session 2 - Radiobiology

Chairperson: Siamak Haghdoost

13:10-13:50 Mechanisms of therapy-related carcinogenesis, James M. Allan  

13:50-14:30 Photons – radiobiological issues related to the risk of second malignancies, Loredana Marcu

Coffee break

14:50-15:50 Special features of the stochastic effects of radiation in particle therapy, Klaus Trott

Coffee break

16:15-17:00 General discussion Moderator: Mats Harms-Ringdahl

19:30  Conference dinner  

Session 3 - Dosimetry

Chairperson: Irena Gudowska

09:00-09:40 Secondary doses from particle therapy, Wayne D. Newhauser

09:40-10:20 Radiation doses from imaging, Teemu Siiskonen

Coffee break

10:40-11:20 Measuring secondary doses in RT, Stephen F. Kry

11:20-12:00 Input to epidemiological studies and dose-risk models, Roger Harrison

Lunch break

Session 4 – Risk of secondary cancer models

Chairperson: Iuliana Toma-Dasu

13:00-13:40 Review of the risk models for radiotherapy, Alexandru Dasu

13:40-14:20 Bridging epidemiology and modelling, Uwe Schneider

Coffee break

14:40-15:10 Risk of secondary cancers after radiotherapy of malign diseases, Ludvig Muren

15:10-15:40 Risk of secondary cancers after radiotherapy for benign diseases, John Damilakis

Coffee break

16:00-16:30 Acknowledging the complexity of risk information, Mats Hansson

16:30-17:00 General discussion and concluding remarks Moderator: Andrzej Wojcik